Article History
Accepted: 15 May 2025
First Online: 13 June 2025
Competing interests
: J.C.M.W. and N.R. are inventors on patents for methods of circulating tumour DNA detection. J.C.M.W. is a consultant for, co-founder and shareholder of Prima Mente and has been a consultant for Cleary Gottlieb, Delfi Diagnostics and Rostrum. P.S. is compensated by Grail for time spent on their advisory board and is also Director of the Cancer Prevention Trials Unit at Queen Mary University of London, which is contracted by GRAIL to act as the clinical trials unit for the NHS-Galleri trial.